Drugs in the treatment of telogen hair loss

Download full text PDF
DOI: https://doi.org/10.29296/25419218-2019-05-03
Issue: 
5
Year: 
2019

I.M. Korsunskaya(1, 2), O.O. Melnichenko(1, 2) 1-Center for Theoretical Problems of Physicochemical Pharmacology, Russian Academy of Sciences, 4, Kosygin St., Moscow 119991, Russian Federation; 2-Moscow Research and Practical Center for Dermatovenereology and Cosmetology, Moscow Healthcare Department, Moscow, Russia, 20, Seleznevskaya St., Moscow 127473, Russian Federation

Telogen hair loss is a common type of alopecia. It is characterized by a sudden onset and can occur in both women and men at any age. Factors that can provoke both acute and chronic telogen hair loss, as well as drugs used in its therapy are considered. Exogenous (drugs and various chemicals) and endogenous (infectious diseases) intoxications play a substantial role in the development of this disease. Drug therapy for telogen hair shedding is based on the correction of nutrient, vitamin, and mineral deficiencies. The vitamin and mineral complexes prescribed should contain protein, essential fatty acids, zinc, selenium, copper, vitamin C, biotin, vitamins B, L-cysteine, if necessary, iron, copper, and folic acid. The patients with telogen hair loss may have a favorable prognosis when the causal factors are eliminated.
Keywords: 
telogen hair loss
alopecia
therapy
vitamin and mineral complex
References: 
  1. Werner B., Mulinari-Brenner F. Clinical and histological challenge in the differential diagnosis of diffuse alopecia: female androgenetic alopecia, telogen effluvium and alopecia areata. Part II. An. Bras. Dermatol., 2012 Nov-Dec; 87 (6): 884–890.
  2. Bing Zhang, Ya-Chieh Hsu. Emerging roles of transit-amplifying cells in tissue regeneration and cancer. Wiley Interdiscip. Rev. Dev. Biol., 2017 Sep; 6 (5): 10.
  3. Gilmore S., Sinclair R. Chronic telogen effluvium is due to a reduction in the variance of anagen duration. Australas J. Dermatol., 2010; 51 (3): 163–167.
  4. Mulinari-Brenner F., Bergfeld W. Entendendo o Eflúvio Telógeno. An. Bras. Dermatol., 2002; 77: 87–94.
  5. Rushton D.H. Nutritional factors and hair loss. Clin. Exp. Dermatol., 2002; 27(5): 396–404.
  6. Ong K.H., Tan H.L., Lai H.C., Kuperan P. Accuracy of various iron parameters in the prediction of iron deficiency in an acute care hospital. Ann. Acad. Med. Singapore., 2005 Aug; 34(7): 437–440.
  7. Sinclair R. There is no clear association between low serum ferritin and chronic diffuse telogen hair loss. Br. J. Dermatol., 2002 Nov; 147(5): 982–984.
  8. Sobolev V., Sakaniya L., TretiakovA.et al. Association of GA genotype of SNP rs4680 in COMT gene with psoriasis. Arch. Dermatol. Res. 2019; 311 (4): 309–315.
  9. Klimov E., Tretiakov A., Gapanovich E. et al. Assessment of the Role of NO Synthase Genes Polymorphisms in the Pathogenesis of Psoriasis. Journal of Advances in Medicine and Medical Research. 2018; 26 (4): 1–6. Article no.JAMMR.41039. https://doi.org/10.9734/JAMMR/2018/41039.
  10. Sobolev V.V., Tret'jakov A.V., Shevtsova A.A. i dr. Svjaz' mezhdu odnonukleotidnoj zamenoj T>C v gene MIR22 i razvitiem psoriaza. Effektivnaja farmakoterapija,2018; 34: 18–20. [Sobolev V.V., Tretiakov A.V., Shevztova A.A. et al. The relationship between single nucleotide substitution T>C in the gene MIR22 and the development of psoriasis. Effektivnaya farmakoterapiya, 2018; 34: 18–20 (in Russian)].
  11. Klimov E.A., Malahova A.V., Korobejnikova L.A. i dr.Assotsiatsii polimorfnyh variantov genov holetsistokininergicheskoj sistemy s panicheskim rasstrojstvom. Meditsinskij sovet, 2018; 12: 190-194. DOI:10.21518/2079-701X-2018-12 [Klimov E.A., Malakhova A.V., Korobeynikova L.A. et al. Associations of polymorphic variants of the cholecystokinergic system genes with panic disorder. Meditsinskiy sovet, 2018; 12: 190-194. https://doi.org/10.21518/2079-701X-2018-12 (in Russian)].
  12. Denisova E.V., Dvorjankova E.V., Plieva K.T.i dr. Patologii gepatobiliarnoj sistemy u bol'nyh psoriazom. Effektivnaja farmakoterapija, 2018; 21: 18-23.[Denisova Ye.V., Dvoryankova Ye.V., Plieva K.T. et al.. Pathology of the hepatobiliary system in patients with psoriasis. Effektivnaya farmakoterapiya, 2018; 21: 18–23 (in Russian)]
  13. Dermatovenerologija. Natsional'noe rukovodstvo. (pod red. Ju.S. Butova, Ju.K. Skripkina, O.L. Ivanova.). M.: GEOTAR-Media, 2013; 896. [Dermatovenereology. National leadership. (by ed. Yu.S. Butov, Yu.K. Skripkin, O.L. Ivanov). Moscow: GEOTAR-Media, 2013; 896. (in Russian) ]
  14. Ral'f M. Trjub. Slozhnyj patsient trihologa. Rukovodstvo po effektivnomu lecheniju alopetsij i soputstvujuschih zabolevanij. M.: GEOTAR-Media, 2018; 392. [Ralph M. Trub. Difficult patient trichologist. Guidelines for the effective treatment of alopecia and related diseases. Moscow: GEOTAR-Media, 2018; 392 (in Russian)].
  15. Gadzhigoroeva A.G. Klinicheskaja trihologija. M.: Prakti-
  16. cheskaja meditsina, 2014; 184. [Gadzhigoroyeva A.G. Clinical tricho-
  17. logy. Moscow: Prakticheskaya meditsina, 2014; 184 (in Russian)].